chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reports by the time he was in his vehicle he was experiencing a "funny feeling" in his throat and sinuses, and had stuffiness & drainage from nose. Vaccine given on Friday AM, 12/12/03. By Sunday, client had continued upper respiratory symptoms and severe, sharp pain in knees and shoulder joints. Also complains of chills with symptoms bad enough to go to bed with. States this is unusual for him as he rarely gets these types of symptoms. By Tuesday, client was better and able to attend classes at school. Within another 10 days, the upper respiratory symptoms returned and persisted. Client was able to function and continue going to classes. About 3 weeks following the shot, the upper respiratory symptoms returned again. This time the client experienced "severe paralysis" in his arms. He describes severe pain in his elbows with burning on his skin 1/2 way down his forearm and numbness from there to his wrists. He states the left was slightly worse than the right. The symptoms gradually improved until the first week in March. Client states the week of March 1st, he experienced "paralysis", burning, tingling, and numbness again to the point of being unable to write or use his computer. He states if he pinched his forearm, he was unable to feel it. He states his fingers could not move and he was unable to make a fist. He also describes neck stiffness and rigidity, lower back pain, and pain and stiffness in his calves. He describes having to use both arms to be able to pick up a textbook in class. On March 5th he saw his physician, who suggested among other things that it might be a reaction to the flu shot. He states he is still having tingling sensations in his hands. Denies any redness or swelling. Is to see a new physician on Monday 3/29/04 and has a return appt. with doctor on Friday 4/2/04.
Patient stated she started having chills, achiness and had a temperature the evening of the vaccine and continued into the next day. Her arm developed redness from her axillary area down to her elbow on the arm she received the vaccination. She had decreased appetite on 9/15, but she said she has slightly improved and does not feel (hopefully) warranting a doctor visit since she has improved since yesterday.
I was in the grocery store and I became dizzy. When I got to my car, I was throwing up and I could barely walk. Everything was spinning. I went to the ER and had a MRI. Then I was diagnosed with Vertigo Syndrome. I was sent home. I went to see my doctor a couple of days after that. The doctor told me I will gradually get better. A few weeks later, I went to a physical therapist. I was given some exercises to do to speed my recovery. I am still not completely over it. I still get dizzy and I get very tired.
Daughter-in-law called earlier this week to report that  has passed away on March 10, 2021.
Complaining of chest tightness in the morning, then it progressed to pain, subjective fever, chest, rashes on arm and face, shivering.  Feels throat is tightening.
sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after first dose) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concurrent medical conditions included Blood pressure abnormal and Thyroid disorder NOS. Concomitant products included VITAMINS NOS for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (sore arm after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is on concomitant medications of blood pressure, thyroid, and vitamins. No treatment medication information was provided.   This case was linked to MODERNATX, INC.-MOD-2021-068306 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: TCR on 20-May-2021 included no new information.; Sender's Comments: MODERNATX, INC.-MOD-2021-068306:2nd Dose
Diarrhea, chills, injection site soreness; Diarrhea, chills, injection site soreness; Diarrhea, chills, injection site soreness; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: Ek9231), via intramuscular route of administration, on 29Dec2020 at 08:45 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization. Relevant medical history was none. Past drug history was allergy to Pediazole. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Dec2020, at 07:30: AM, the patient experienced diarrhea, chills and vaccination site soreness. No treatment was received for the events diarrhea, chills and vaccination site soreness. The outcome of the events diarrhea, chills and vaccination site soreness was not recovered. Since the vaccination, the patient had not been tested for COVID-19.
CHANGE IN SENSE OF SMELL. CHANGE IN SENSE OF TASTE. CHANGES IN TASTE/SMELL WERE A GREATER SENSITIVITY TO MANY ODORS AND A RADICAL SHIFT IN HOW FOOD TASTES. MANY FOODS BECAME INEDIBLE TO ME.
Right arm is red and hot (from shoulder to elbow) to the touch. Patient states it started late Saturday evening after receiving the vaccine on Friday.
ACUTE NON ST ELEVATION MI 4/18/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE RESPIRATORY FAILURE 4/10/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/18/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA HYPOXIA 4/10/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE NON ST ELEVATION MI 4/18/2023 PROTEIN CALORIE MALNUTRITION, UNSPECIFIED SEVERITY ACUTE RESPIRATORY FAILURE 4/10/2023 PROTEIN CALORIE MALNUTRITION, UNSPECIFIED SEVERITY ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/18/2023 PROTEIN CALORIE MALNUTRITION, UNSPECIFIED SEVERITY HYPOXIA 4/10/2023 PROTEIN CALORIE MALNUTRITION, UNSPECIFIED SEVERITY ACUTE NON ST ELEVATION MI 4/18/2023 ACUTE NON ST ELEVATION MI    CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE RESPIRATORY FAILURE 4/10/2023 ACUTE NON ST ELEVATION MI    CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/18/2023 ACUTE NON ST ELEVATION MI    CAD (CORONARY ARTERY DISEASE) WO ANGINA HYPOXIA 4/10/2023 ACUTE NON ST ELEVATION MI    CAD (CORONARY ARTERY DISEASE) WO ANGINA
stated the patient was in a wheelchair on 08Jul2021; Patients vaccinated with expired use; the 4 patients that received the COVID-19 Vaccine involved in the temperature excursion.; the 4 patients that received the COVID-19 Vaccine involved in the temperature excursion.; This is a spontaneous report from a contactable other hcp. This other HCP reported similar events for 4 patients. This report is for 4th of 4 report.  A 18-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0196; Expiration Date: 30Sep2021), dose 1 via an unspecified route of administration, administered in Deltoid Left on 08Jul2021(at the age of 18 years) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced stated the patient was in a wheelchair on 08Jul2021 on an unspecified date, patients vaccinated with expired use on 08Jul2021, the 4 patients that received the covid-19 vaccine involved in the temperature excursion. on 08Jul2021.Patient stated, 4 patients vaccinated with the Pfizer Covid vaccine which was stored in the freezer since 08Jun2021. Reporter is looking for guidance on how to proceed. office manager reported their practice had kept the COVID-19 Vaccine in the freezer since 08Jun2021, past the allowed extended freezer time, and then the COVID-19 Vaccine was then given to 4 patients. said the COVID-19 Vaccine can only be kept in the freezer for 3 weeks. a temperature excursion had occurred on the practice's COVID-19 Vaccine, and the practice's office manager was being transferred to report on the 4 patients that received the COVID-19 Vaccine involved in the temperature excursion. Reported the patient was unaware the COVID-19 Vaccine was involved in a temperature excursion, and the patient had not reported any adverse events to their office since the COVID-19 Vaccine was administered. Patient not received treatment for reported events. The outcome of events was unknown.; Sender's Comments: Based on the available information, there is a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported event disability cannot be fully assessed/excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202100922637 same reporter/product/event, different patient
minimal discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (minimal discomfort) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (minimal discomfort). At the time of the report, DISCOMFORT (minimal discomfort) outcome was unknown.            No Concomitant medications were reported. No Treatment information was reported.
Dose 1: Bruising and soreness at injection site within first 24 hours.  Swollen lymph nodes under right arm a few days after first shot received no soreness - had virtual visit with PCP office just as a follow up approx. a week and a half after noticed lymph nodes had swelled. Dose 2: Slight headache and fatigue within the first two hours after second shot received.  Swollen lymph nodes under right arm within 24 hours of second shot with some soreness.
arm  tingly and numb (started then came back); Lymph nodes really sore; extremely depressed; nausea; exhausted; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (arm  tingly and numb (started then came back)), LYMPH NODE PAIN (Lymph nodes really sore), DEPRESSION (extremely depressed), NAUSEA (nausea) and FATIGUE (exhausted) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced HYPOAESTHESIA (arm  tingly and numb (started then came back)), LYMPH NODE PAIN (Lymph nodes really sore), DEPRESSION (extremely depressed), NAUSEA (nausea), FATIGUE (exhausted) and HEADACHE (headache). On 18-Apr-2021, DEPRESSION (extremely depressed), NAUSEA (nausea) and HEADACHE (headache) had resolved. At the time of the report, HYPOAESTHESIA (arm  tingly and numb (started then came back)), LYMPH NODE PAIN (Lymph nodes really sore) and FATIGUE (exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
I experienced ringing in my left ear , non stop since the J&J vaccine about 5 minutes. I also have ringing in my right ear also have had a pressure headache since the moment of vaccine.  I seen doctors, had ears cleaned, hearing tests, have seen an ENT specialist and also have had an MRI. MRI was to make sure there was no tumors in my ears, my results were negative. Lab work done for blood clots which were also negative.  Today I still continue to experience these symptoms.
Area of immunization and area surrounding swelled considerately. Hot to the touch. Bruised appearance. PCP put her on 10 days of medication. Took 6-8 weeks to clear up.
Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction); This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction)). At the time of the report, ADVERSE REACTION (Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details pertained to the events were provided.   Reporter did not allow further contact
Reported by patients wife. She Reports blood clot in left leg "from thigh to calf".  Treated with blood thinners since beginning of March 2021.  Has taken Enoxaparin Sodium 100mg bid since onset and recently started on Xarelto by hematologist 04/16/2021.
5 days later, developed tinnitus, hand numbness, flu like symptoms, fever. It had SARS in 2003 following a business trip to another country. Have been to 9 difference doctors. Per neurologist symptoms are permanent. I had steroid shots. Nerves in legs are gone.
lt upper arm 7cm swelling & erythema; pain radiating to neck & down lt arm; pt feels weak & dizzy; tx DPH;
No adverse event; vaccine was administered past expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date) and NO ADVERSE EVENT (No adverse event) in a 31-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 037A22B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Nov-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 14-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine was administered past expiration date).    Concomitant drugs were not reported. It was reported that the monovalent opened vial of 5.5 ml size was initially stored in the refrigerator on 14-Nov-2022. The vial did not underwent any temperature excursion. No additional doses, medications, or treatments were reported.
PT RECEIVED FIRST COVID VACCINE. AFTER ABOUT 10 MIN PT REPORTED DIZZINESS AND MILD TIGHTNING IN THROAT. PT BROUGHT BACK TO EXAM ROOM FOR OBSERVATION AND VITALS. VITALS STABLE. PT REPORTED TONGUE SWELLING AND TINGLING IN LIPS. md CONSULTED. 25MG BENEDRYL GIVEN PO. PT NOT IMPROVING. EMS CALLED AND TOOK OVER
blood clots in greater saphenous vein; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Apr2021 08:00 at single dose in left arm (at the age of 55-year-old) for COVID-19 immunization. Medical history included covid-19. Concomitant medication included iodine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. On 15Apr2021, the patient experienced blood clots in greater saphenous vein. The event resulted in Doctor or other healthcare professional office/clinic visit. Treatment received included Eliquis. The outcome of the event was unknown.  Information about batch/lot number has been requested.
This spontaneous report was received from a registered nurse concerning a 26 year old female patient. The patient's medical history included abnormal Papanicolaou (pap) smears. Her concurrent conditions were not reported and there was no drug reactions or allergies to be reported. Concomitant medications included levonorgestrel (MIRENA). On 05-JUL-2018, the patient received the first dose of GARDASIL 9, lot number: N026812 (expiration date: 22-JUN-2020) intramuscularly (strength, dose and frequency not reported) for prophylaxis. On 05-AUG-2018, after the first dose of GARDASIL 9, the patient experienced itchiness on her hands and feet (extremities itchy sensation) and all over her body (pruritus generalized). She sought for medical attention and received treatment (unspecified) for the events. No lab diagnostic or studies were performed. The patient recovered from the events on an unspecified date. There was no product quality complaint (PQC) reported. The causality between the events and GARDASIL 9 was unknown.
Patient developed 2009 H1N1 several weeks after being vaccinated with FLUMIST. Confirmed by Lab test.
Patient presents for Tdap vaccine along with EMS due to previous history of anaphylaxis with administration of a vaccine.  Arm prepped and vaccine administered without complications.  Patient immediately felt throat start to close and was laid down on exam table.  EMS at bedside and provided care. Transport to hospital via ambulance.
Patient states she felt numbness and tingling in left arm immediately when vaccine was given to her.  "I can feel the vaccine moving through my arm."  When checked at 15 minutes post injection she said her arm was bothering her and she was shaking her hand and holding her arm.  One hour later she noticed her watch was tight on her wrist.  Two hours later she had the sensation she was floating through the air and was lightheaded.  She took her watch off 2-3 hours post injection and noticed that she had "sausage fingers".  She had difficulty getting her rings off her fingers due to the swelling. Patient calls to report these symptoms 5/6/2021 at 9:40 am.  She states the swelling is resolving and her fingers are almost
This spontaneous report as received from a consumer via social media refers to a 15 year old female patient (reporter friend's daughter). The patient's medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patient was vaccinated with all three doses of either quadrivalent human papillomavirus (types 6, 11, 16, 18) recomb. vaccine (manufacturer unknown) or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (manufacturer unknown), (dose, route, lot # and expiry date not reported). On an unknown date, the patient died after receiving all three doses of vaccine. The cause of death was unknown and it was not reported if an autopsy was performed. The reporter stated that, his/her friend did some research and she was convinced that the patient died because of this vaccine. The reporter also stated that his/her kids had received all other vaccines,  but this vaccine had many risks. Causality was not provided by the reporter. No product quality complaint was involved. Upon internal  review, death was determined to be medically significant. Additional information is not expected as contact details of the reporter are not available.
Got a surgery; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (Got a surgery) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced SURGERY (Got a surgery). At the time of the report, SURGERY (Got a surgery) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Dose 1:fatigue, arm stiffness Dose2: Major Fatigue, body ache, headache, Chills large swelling under right arm (lymph nodes)  Breakthrough Covid infection (06/15/2021)  after vaccine series
Immediately after administration patient stated that she  has 'burning feeling' in her abdominal area, that worsened over next 15 minutes and spreaded to extremities, neck areas. She was feeling dizzy and "not well". No problems breathing were reported, no tingling, no rash. Patient was not feeling any better after 20 minute and the ambulance was called. On their arrival patient was checked, vital signs taken,  concluded that there was no immediate danger, recommended to stay seated for 15 more minutes, have some water and report if situation worsens. Patient started feeling better after paramedics left and was able to leave after 15 minutes.